Ethypharm agrees European Argatroban business acquisition
Acquisition17/06/2024
Ethypharm announced an agreement with Mitsubishi Tanabe Pharma Corporation to acquire its European Argatroban monohydrate business. The disclosed brands were Argatra, Arganova, Novastan and Exembol. The transaction concerned a medicine portfolio in Europe, not an acquisition of Mitsubishi Tanabe Pharma itself. Ethypharm positioned the agreement within its expansion through internal development, licensing and acquisitions. The source describes an agreement and does not independently establish closing, consideration or the precise acquiring group subsidiary. The announced date is 17 June 2024, as printed in the release, despite the later date embedded in its filename.
Type
Acquisition
Announced
17/06/2024
Amount
Financial data requires access